A5 Nb significantly inhibited migration and invasion of CD155-overexpressing lung cancer cells at concentrations more than tenfold lower than those required for conventional antibodies, suggesting superior potency and potential for safer dosing strategies (Supplementary Fig. 3, 4). The gene discussed is PVR; the disease is lung carcinoma.